Meeting
Abstract Number: 263
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Inpatient hospitalization represents a key time for patients who use tobacco to quit smoking, and inpatients who receive smoking cessation counseling, nicotine replacement, and referral to outpatient resources have increased quit rates six weeks after hospital discharge. However, in 2014, only 34.5% of tobacco users admitted to our 600-bed academic hospital were documented as […]
Abstract Number: 460
Hospital Medicine 2020, Virtual Competition
Background: Hospitalization provides an opportunity to provide patients who use tobacco with evidence-based treatment for cessation, including nicotine replacement therapy, motivational interviewing, and pharmacotherapy. However, this benefit is often lost without appropriate transitions in care to outpatient cessation resources. We have found that inpatient tobacco cessation interventions at our 600-bed urban academic medical center do […]
Abstract Number: 585
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 56-year-old man with a medical history of nicotine dependence, gastroesophageal disease (GERD) and chronic obstructive pulmonary disease (COPD) emphysema sub-type presented to the outpatient clinic for the evaluation of cough and shortness of breath. Cough was said to be productive of light-yellow sputum and he denied any associated fevers or chest pain. […]
Abstract Number: A17
SHM Converge 2022
Background: Although most cigarette smokers want to quit, current cessation therapies have limited effectiveness. Preventing relapse is limited by insufficient understanding of the neural pathways that are triggered during relapse. With recent advances in functional connectivity analysis, functional magnetic resonance imaging (fMRI) studies offer the ability to better neural functional connectivity during relapse. This study […]